Lorenzo Valerio
Colleretto Giacosa, Piemonte, Italia
626 follower
Oltre 500 collegamenti
Informazioni
During my research career, I have had the excellent opportunity to work in a…
Attività
-
Join Eleonora Maggioni and me for the Special Session on Advances in Multimodal and Multiparametric analysis for functional brain research - MMBrain…
Join Eleonora Maggioni and me for the Special Session on Advances in Multimodal and Multiparametric analysis for functional brain research - MMBrain…
Consigliato da Lorenzo Valerio
-
🌟 What an inspiring end to our 2025 conference season at #PCRLondonValve! For Tresquare Technologies and its CEO Stefano Pasquino, this London…
🌟 What an inspiring end to our 2025 conference season at #PCRLondonValve! For Tresquare Technologies and its CEO Stefano Pasquino, this London…
Consigliato da Lorenzo Valerio
-
...have a nice first Compamed 2025 day... 8B-C35
...have a nice first Compamed 2025 day... 8B-C35
Consigliato da Lorenzo Valerio
Esperienza
-
-
-
-
-
-
-
-
-
Formazione
-
Politecnico di Milano
PhD degree Cum Laude
-
Attività e associazioni:PhD activities conducted in collaboration between Politecnico di Milano and San Raffaele Hospital. Activities at San Raffaele Hospital: management and maintenance of different mechanical circulatory support devices. Management of activities regarding the phases of hospitalization and discharge of patients with different ventricular assist devices (VADs). PhD activities at Politecnico di Milano: Analysis of the thrombogenicity of different cardiovascular devices in vitro.
PhD thesis: Multi-perspective investigation of the effectiveness of anti-thrombotic treatments in association with shear-mediated platelet activation.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Licenze e certificazioni
Pubblicazioni
-
Microfluidic approaches for the assessment of blood cell trauma: a focus on thrombotic risk in mechanical circulatory support devices
International Journal of Artificial Organs
-
Shear-Mediated Platelet Activation in Patients Implanted with Continuous Flow LVADs: A Preliminary Study Utilizing the Platelet Activity State (PAS) Assay
IEEE EMBS
Contributed paper for the 37th Conf Proc IEEE Eng Med Biol Soc, 25-29 August 2015, Milano (Italy)
Altri autori -
-
Do Current Anti-Platelet Agents Truly Provide Protection Against Shear-Mediated Platelet Activation in Mechanical Circulatory Support?
ISHLT
Contributed paper for the 34th Annual Meeting and Scientific Session, ISHLT, April 10-13, 2014, San Diego (California - USA)
Altri autori -
-
In vitro hemodynamics and valve imaging in passive beating hearts
Journal of Biomechanics
Riconoscimenti e premi
-
International Scholarship
International Society of Rotary Blood Pumps (ISRBP)
Winning project. International Scholarship Call – “Do Current Anti-Platelet Agents Truly Protect Platelets Against Actual Shear Exposure Experienced in Passage through Ventricular Assist Devices?”.
The project won the competition for a scholarship banned from the International Society of Rotary Blood Pumps (ISRBP) for supporting international cooperative research 2013.
Lingue
-
Inglese
Conoscenza professionale completa
-
Italiano
Conoscenza madrelingua o bilingue
Altre attività di Lorenzo
-
The first patients enrolled in the SAITO 1B trial at Macquarie University Hospital using the TAVIPILOT AI based software to assist TAVI. This imaging…
The first patients enrolled in the SAITO 1B trial at Macquarie University Hospital using the TAVIPILOT AI based software to assist TAVI. This imaging…
Consigliato da Lorenzo Valerio
-
Meet us at Halle 8b stand C35 Compamed 🎉 #COMPAMED #MEDICALDEVICES
Meet us at Halle 8b stand C35 Compamed 🎉 #COMPAMED #MEDICALDEVICES
Consigliato da Lorenzo Valerio
-
Excited to be back at PCR London Valves! Tomorrow I’ll be presenting “Fourteen-Year Tricuspid Valve-in-Valve: The Longest Reported Follow-up” — a…
Excited to be back at PCR London Valves! Tomorrow I’ll be presenting “Fourteen-Year Tricuspid Valve-in-Valve: The Longest Reported Follow-up” — a…
Consigliato da Lorenzo Valerio
-
Excited to share that I will be attending MEDICA - Leading International Trade Fair 2025 / COMPAMED – Düsseldorf / Deutschland on November 17-19. As…
Excited to share that I will be attending MEDICA - Leading International Trade Fair 2025 / COMPAMED – Düsseldorf / Deutschland on November 17-19. As…
Consigliato da Lorenzo Valerio
-
🚀 Exciting news! At the upcoming London Valves 2025, we will present TRESECT®, our innovative transcatheter device, the only system capable of…
🚀 Exciting news! At the upcoming London Valves 2025, we will present TRESECT®, our innovative transcatheter device, the only system capable of…
Consigliato da Lorenzo Valerio
-
London is calling! 📞 AorticLab will be at London Valves 2025, ready to connect and share insights with the cardiovascular community. Want to…
London is calling! 📞 AorticLab will be at London Valves 2025, ready to connect and share insights with the cardiovascular community. Want to…
Consigliato da Lorenzo Valerio
-
🫀 𝙀𝙥𝙮𝙜𝙤𝙣 back in the spotlight! Don’t miss the upcoming presentation by Prof. mohammad sarraf at PCR London Valve 👇 Interventional…
🫀 𝙀𝙥𝙮𝙜𝙤𝙣 back in the spotlight! Don’t miss the upcoming presentation by Prof. mohammad sarraf at PCR London Valve 👇 Interventional…
Consigliato da Lorenzo Valerio
-
✨ Una nuova avventura sta iniziando. Oggi mi affaccio a questo nuovo capitolo con il ❤️ colmo di gioia e tanta 𝐦𝐨𝐭𝐢𝐯𝐚𝐳𝐢𝐨𝐧𝐞. Ogni…
✨ Una nuova avventura sta iniziando. Oggi mi affaccio a questo nuovo capitolo con il ❤️ colmo di gioia e tanta 𝐦𝐨𝐭𝐢𝐯𝐚𝐳𝐢𝐨𝐧𝐞. Ogni…
Consigliato da Lorenzo Valerio
Altri profili simili
Esplora altri post
-
Antje Hellwich
Advanced Imaging in Cardio-Oncology: Cardiac Magnetic Resonance for #Cardiotoxicity Assessment by Federica Brilli, M.D.; Marco Francone, M.D., Ph.D.; et al. (Department of Biomedical Sciences, Humanitas University, Milan, Italy & IRCCS Humanitas Research Hospital, Milan, Italy) Advancements in cancer therapies have significantly improved survival rates, leading to a growing number of cancer survivors. However, this success also brings increased attention to therapy-related side effects—especially cardiovascular complications—which may manifest both acutely and chronically. In 2022, the International Cardio-Oncology Society (IC-OS) introduced a consensus definition for cancer therapy-related cardiac dysfunction (CTRCD), which includes conditions such as cardiomyopathy, heart failure (HF), myocarditis, vascular toxicity, hypertension (HTN), arrhythmias, and QT interval prolongation associated with anticancer treatments. This comprehensive framework aims to address long-standing issues of misclassification and misdiagnosis in the field. That same year, the European Society of Cardiology (ESC) published its first cardio-oncology guidelines, setting international standards for diagnosing and managing cancer therapy-related cardiovascular toxicity (CTR-CVT). This initiative involved collaboration with the European Hematology Association (EHA), the European Society for Radiotherapy and Oncology (ESTRO), and the International Cardio-Oncology Society, underscoring the need for a systematic approach to managing cardiovascular toxicities in cancer patients. The ESC guidelines emphasize early detection, risk assessment, and preventive measures to improve outcomes for this at-risk population. The authors show how cardiac magnetic resonance (#CMR) imaging has become an essential tool in the early detection and management of chemotherapy-induced cardiotoxicity, offering significant financial, operational, and clinical advantages. 👉 Read more: https://lnkd.in/ePDf4qiV Shoutout to the co-authors: Costanza Lisi, M.D.; Stefano Figliozzi, M.D.; Federica Catapano, M.D. #MagnetomWorld #WhyCMR #MRI #CardioOncology Domenico Zaca Gaia Banks Siemens Healthineers
1 commento -
Sergio Occhipinti
We’re proud to announce that NIB biotec has been granted patents in both Japan and China for our proprietary technology using urinary biomarkers for the diagnosis of prostate cancer. This milestone marks a strategic leap forward, strengthening our presence in two of the world’s most dynamic and fast-growing healthcare markets. 🔬 Prostate cancer is a growing health concern in Asia, with over 104,000 new cases annually in Japan and a rapidly increasing incidence in China due to aging populations. Our non-invasive, accurate diagnostic approach offers a powerful tool for early detection. #nibbiotec
8 commenti -
Nina C. Wunderlich, MD, FESC, FACC
Why a New Implanter Classification for LAAC Matters Evaluating procedural complexity before the case helps match the right skills to the right patient, streamline team planning, guide training pathways, and benchmark outcomes more fairly. The ELAACC’s new implanter classification offers a shared language to do exactly that. Read the EuroIntervention paper: https://lnkd.in/efgjyUzj #LAAC #StructuralHeart #ELAACC #EuroIntervention #JensErikNielsenKudsk #AdelAminian #OleDeBacker #XavierIriart #SergioBerti #RobertoGalea #XavierFreixa #LorenzRaeber #IgnacioCruzGonzalez #NinaCWunderlich #PhilippeGarot
Altre persone che si chiamano Lorenzo Valerio in Italia
Su LinkedIn ci sono altre 14 persone che si chiamano Lorenzo Valerio in Italia
Vedi altre persone che si chiamano Lorenzo Valerio